The findings come from an observational study using two prospective population cohorts: 82,222 participants from the UK Biobank and 16,842 participants from the US National Health and Nutrition Examination Survey, or NHANES. The UK Biobank participants were drawn from dietary and health data collected between 2006 and 2010, while the NHANES analysis covered survey cycles from 2005 through 2018. Individuals with incomplete dietary information, missing outcome data, incomplete covariates or CKM stage 4—defined by established cardiovascular disease—were excluded. The researchers then followed participants through linked hospital and mortality records. Their primary cardiovascular endpoint, known as MACE, combined cardiovascular death, nonfatal myocardial infarction and stroke. All-cause mortality was also assessed, while NHANES analyses focused on mortality because reliable data on nonfatal cardiovascular events were unavailable.

CKM syndrome is designed to capture a continuum rather than a single diagnosis. Stage 0 describes people without recognized metabolic or kidney risk factors, while stage 1 includes elevated body mass index, increased waist circumference or prediabetes. Stage 2 incorporates conditions such as hypertension, diabetes, metabolic syndrome and moderate-to-high-risk chronic kidney disease. Stage 3 identifies people with very high-risk kidney disease or a predicted 10-year cardiovascular disease risk of at least 20 percent, even when overt cardiovascular disease has not yet been reported. This approach matters because metabolic dysfunction, kidney impairment and vascular injury often develop together for years before a heart attack or stroke occurs. Diet may influence that trajectory through several biological routes at once, including blood pressure, insulin sensitivity, lipid metabolism, oxidative stress and immune activation.

To measure diet quality, the investigators used different tools in the two cohorts because the available dietary data were not identical. The alternative Mediterranean diet, or AMED, score assessed nine components, rewarding higher intake of foods such as fruits, vegetables and whole grains while assigning reverse scores to red and processed meat and other less favorable components. The healthful plant-based diet index, or HPDI, divided foods into healthful plant foods, less healthful plant foods and animal-derived foods. Whole grains, fruits and vegetables received positive weights, whereas refined grains, sugary foods and animal foods received inverse weights. The researchers also calculated the Dietary Inflammatory Index, or DII, which estimates the inflammatory potential of a diet using as many as 45 food components. Positive scores indicate a more pro-inflammatory pattern, while negative scores indicate a more anti-inflammatory one. NHANES data allowed analysis of 28 components.

The associations were substantial but varied between measures and populations. In the UK Biobank, each standard-deviation increase in HPDI score was associated with a hazard ratio of 0.95 for MACE and 0.90 for all-cause mortality. For AMED, the corresponding hazard ratios were 0.93 for MACE and 0.90 for all-cause mortality. In practical terms, these estimates indicate roughly 5 to 10 percent lower relative risks for each standard-deviation improvement in the scores after adjustment for age, sex, ethnicity, education, socioeconomic status, smoking, alcohol use, physical activity, energy intake, body mass index and diabetes history. Compared with participants in the lowest score tertile, those in the highest HPDI and AMED tertiles had 11 percent and 13 percent lower risks of MACE, respectively. The study also linked higher HPDI scores to a 10 percent lower risk of cardiovascular death and a 6 percent lower risk of stroke, while higher AMED scores were associated with an 8 percent lower risk of cardiovascular death and a 9 percent lower risk of myocardial infarction.

The signal was especially clear for dietary inflammation. In NHANES, each standard-deviation increase in DII was associated with an 18 percent higher risk of both all-cause mortality and cardiovascular mortality. Compared with people in the lowest DII tertile, those in the highest had 38 percent higher all-cause mortality and 50 percent higher cardiovascular mortality. Conversely, each standard-deviation increase in AMED score was associated with a 12 percent reduction in all-cause mortality in NHANES. The researchers found no consistent nonlinear relationship between the dietary scores and mortality, myocardial infarction or cardiovascular death. However, HPDI showed an inverted U-shaped association with MACE, with scores above 60 linked to progressively lower risk, while AMED showed a U-shaped association with stroke. These patterns suggest that dietary effects may not increase in a simple straight line across the entire range of eating behaviors, although the study cannot determine an optimal score for individuals.

The analysis also examined individual vitamins and minerals, revealing a broad pattern of associations rather than a single “magic” nutrient. Higher intakes of alpha-carotene, beta-carotene and vitamin C were associated in both cohorts with lower risks of MACE, all-cause mortality and cardiovascular mortality. In the UK Biobank, participants in the highest alpha-carotene tertile had a 12 percent lower risk of stroke, while those with the highest beta-carotene intake had a 12 percent lower risk of myocardial infarction. Higher vitamin C intake was associated with a 20 percent reduction in cardiovascular mortality. In NHANES, greater intake of niacin, or vitamin B3, and folate, or vitamin B9, was associated with lower risks of all-cause and cardiovascular death. Vitamin E was associated with 9 percent lower all-cause mortality and 23 percent lower cardiovascular mortality for each standard-deviation increase in intake. Among minerals, higher copper, iron and magnesium intake was consistently associated with lower risks of MACE and mortality, with hazard ratios ranging from 0.63 to 0.89 when the highest and lowest intake tertiles were compared. Magnesium and copper were also linked to lower myocardial infarction risk, while zinc was associated with lower stroke risk.

The biological analyses offered clues about how diet might influence CKM outcomes. The researchers tested whether oxidative stress, inflammatory blood markers and phenotypic aging—an estimate of biological aging based on multiple biomarkers—could statistically mediate the diet-outcome associations. In the UK Biobank, phenotypic aging accounted for as much as 29.5 percent of the association between HPDI and MACE and 20.4 percent of the association between AMED and MACE. Oxidative stress measures, including uric acid and the uric-acid-to-HDL cholesterol ratio, accounted for portions ranging from 5.7 to 14.9 percent. White blood cell counts, neutrophils, lymphocytes and C-reactive protein also contributed to the statistical mediation, with proportions generally between 1.3 and 17 percent. In NHANES, uric acid, the uric-acid-to-HDL ratio and neutrophil counts partially mediated the relationships between AMED or DII and cardiovascular mortality. These results are compatible with the idea that plant-rich diets may reduce vascular risk partly by dampening chronic inflammation and oxidative damage while slowing biological aging, but mediation analysis in an observational study does not prove that these pathways are causal.

The researchers caution that the findings should be interpreted as evidence about dietary patterns and whole foods, not as a prescription for high-dose supplements. Nutrients are consumed together, and people who eat more fruits, vegetables, legumes and whole grains may also exercise more, smoke less, have greater access to health care or consume fewer ultra-processed foods. Although the statistical models adjusted for many of these factors, the study could not account for ultra-processed food intake, and the dietary assessments captured baseline habits rather than changes over time. Multiple vitamin and mineral comparisons were exploratory and were not formally corrected for multiple testing, raising the possibility that some associations occurred by chance. Dietary instruments also differed between the UK Biobank and NHANES, and NHANES participants who were excluded for missing information could have introduced selection bias. The analysis did not provide stage-specific guidance for CKM stages 0, 1, 2 and 3, and its participants came from two predominantly Western cohorts. Randomized dietary trials, especially those tracking inflammatory and aging biomarkers, will be needed to determine whether changing diet directly reduces cardiovascular events. For now, the evidence points toward a familiar but increasingly measurable strategy: emphasizing minimally processed plant foods, healthy fats, whole grains and nutrient-dense produce while limiting pro-inflammatory red and processed meat-based eating patterns may help interrupt CKM syndrome before it culminates in irreversible cardiovascular disease.

For decades, the pathophysiology of lipedema has eluded clinicians, with inflammation emerging as a crucial culprit in disease progression. Prior investigations had established elevated systemic inflammatory markers such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in patients, yet the influence of modifiable lifestyle factors like diet remained underexplored. Addressing this gap, the study conducted by Tel Adıgüzel and colleagues focuses on two key dietary metrics: the Dietary Inflammatory Index (DII), which quantifies the inflammatory potential of one’s diet, and the Mediterranean Diet Score (MDS), a well-known indicator of adherence to a nutrient-rich, anti-inflammatory dietary paradigm renowned for its cardiovascular and metabolic benefits.

Involving a cohort exclusively composed of women diagnosed with lipedema, the researchers undertook comprehensive dietary assessments alongside biomarker analyses, striving to delineate how nutritional intake modulates systemic inflammation. Their rigorous methodology entailed scoring dietary records against the DII and MDS scales, followed by precise measurement of circulating TNF-α and IL-6 levels using validated immunoassays. This multifaceted approach allowed the team to correlate dietary inflammatory potential with biochemical evidence of inflammation and clinical features such as pain intensity and fat distribution.

The findings revealed a compelling inverse relationship between adherence to the Mediterranean diet and levels of TNF-α and IL-6, underscoring the diet’s anti-inflammatory properties. Women exhibiting higher Mediterranean Diet Scores demonstrated markedly reduced systemic inflammation, which corresponded with amelioration of clinical symptoms associated with lipedema, including pain and edema. Conversely, participants whose diets ranked high on the Dietary Inflammatory Index showed elevated inflammatory markers, suggesting that pro-inflammatory dietary patterns exacerbate lipedema’s progression and symptom burden.

Notably, this study elucidates the critical role of dietary fat quality and nutrient composition in modulating inflammatory pathways pertinent to lipedema pathology. The Mediterranean diet’s emphasis on monounsaturated fats, antioxidants, fiber, and polyphenols appears to curtail the chronic inflammatory milieu typical of lipedema. These bioactive compounds may suppress nuclear factor-kappa B (NF-κB) signaling and other pro-inflammatory cascades, intervening in adipose tissue dysfunction and systemic immune activation.

From a molecular standpoint, elevated TNF-α and IL-6 perpetuate adipocyte hypertrophy and fibrosis, transforming subcutaneous fat into an inflammatory state that compromises lymphatic drainage and causes pain—hallmarks of lipedema. By associating anti-inflammatory dietary patterns with lowered TNF-α and IL-6, the study suggests that strategic nutritional interventions can modify underlying disease mechanisms rather than merely addressing symptoms.

Clinical implications of these insights cannot be overstated. Lipedema management traditionally revolves around physical therapies and surgical options with variable success rates, while systemic inflammation often remains untreated. The prospect of utilizing diet as a non-pharmacological, accessible adjunct offers hope for improved quality of life and disease modulation without the risks inherent to invasive therapies. Moreover, personalized nutrition plans tailored to reduce dietary inflammation could become integral components of comprehensive lipedema care protocols.

Future research trajectories inspired by this work may include controlled dietary intervention trials that meticulously monitor long-term outcomes and explore additional inflammatory mediators and metabolic pathways. Furthermore, integration of genomics and microbiome analyses might reveal individual responses to dietary modifications and identify biomarkers predictive of therapeutic efficacy. This precision medicine approach could transform lipedema treatment paradigms in the years ahead.

Additionally, public health strategies aimed at raising awareness about the role of diet in inflammatory disorders—especially those predominantly affecting women—may facilitate earlier diagnosis and lifestyle modification, potentially slowing lipedema progression. Given the chronic nature of lipedema and its wide-reaching impact on physical and psychological well-being, such preventive endeavors are vital.

This study also challenges the broader obesity and adiposity research fields by emphasizing heterogeneity within adipose tissue disorders. Unlike classic obesity, lipedema involves selective regional fat accumulation that is resistant to conventional weight loss measures, spotlighting the necessity of distinct therapeutic targets. Understanding diet-inflammation links in this context furthers our grasp of adipose tissue’s complex immunometabolic functions.

Importantly, the multidimensional framework provided by Tel Adıgüzel et al. elucidates how nutritional epidemiology can intersect with molecular biology to unravel chronic disease mechanisms. By operationalizing dietary indices that quantify inflammatory potential and linking them with robust biomarker data, the research provides a replicable model for future investigations in related conditions involving systemic inflammation and adipose tissue dysregulation.

The relationship between lifestyle, immune function, and chronic adipose disorders illuminated in this study represents a paradigm shift. With diet emerging as a modifiable risk factor capable of blunting inflammatory mediators central to lipedema pathogenesis, clinicians have new avenues to enhance patient care. This could eventually extend beyond lipedema to encompass other inflammatory adiposopathies, fostering interdisciplinary collaboration among dietitians, immunologists, and adipose tissue specialists.

In summation, the compelling evidence connecting Mediterranean diet adherence with reduced inflammatory biomarker levels and improved clinical outcomes in women with lipedema underscores the importance of nutritional interventions as a promising therapeutic avenue. This research opens a critical dialogue on the integration of diet-based strategies in the holistic management of lipedema, challenging conventional treatment frameworks and inspiring future innovations aimed at alleviating this enigmatic chronic disease.

As the field evolves, it will be essential to translate these insights into evidence-based guidelines and educational resources to empower patients with lipedema to harness the anti-inflammatory potential of diet. The convergence of nutritional science and adipose tissue biology promises a future where lipedema’s inflammatory underpinnings are effectively targeted, mitigating suffering and enhancing lives.

Subject of Research:
The study investigates the association between dietary inflammatory potential, Mediterranean diet adherence, systemic inflammatory biomarkers (TNF-α and IL-6), and clinical outcomes in women diagnosed with lipedema.

Article Title:
Dietary Inflammatory Index and Mediterranean Diet Score are associated with systemic inflammation in women with lipedema.

Article References:
Tel Adıgüzel, K., Yaman, A., Kürklü, N.S. et al. Dietary Inflammatory Index and Mediterranean Diet Score are associated with systemic inflammation in women with lipedema. Int J Obes (2025). https://doi.org/10.1038/s41366-025-01960-w

Image Credits:
AI Generated

DOI:
27 November 2025

The Mediterranean diet, historically celebrated for its robust health benefits, emphasizes consumption of plant-based foods such as legumes, fruits, vegetables, whole grains, and healthy fats predominantly derived from olive oil. This dietary pattern has been extensively documented to confer protection against cardiovascular disease, neurodegenerative conditions, and certain malignancies. Now, its advantageous impact on periodontal tissues adds another dimension to its role in disease prevention.

In this study, 200 hospital patients enrolled in the King’s College London Oral, Dental and Craniofacial Biobank underwent comprehensive dental examinations, blood analyses, and dietary assessments through detailed questionnaires. Researchers observed that individuals whose dietary intake diverged from a Mediterranean pattern, particularly those with frequent red meat consumption, exhibited more pronounced periodontal inflammation and disease severity. This was characterized by heightened levels of circulating pro-inflammatory mediators including Interleukin-6 (IL-6) and C-reactive protein (CRP), biomarkers widely implicated in systemic inflammatory processes.

The mechanistic underpinnings of these findings are intricately linked to the bioactive compounds abundant in Mediterranean foods. Plant-derived phytochemicals, alongside macro- and micronutrients, possess multifaceted anti-inflammatory properties capable of modulating immune responses. By attenuating the production of cytokines such as IL-6 and acute-phase reactants like CRP, these compounds may foster a systemic milieu less conducive to periodontal tissue destruction.

Significantly, patients adhering to plant-based diets characteristic of the Mediterranean regimen demonstrated lower inflammatory marker profiles, suggesting a protective effect against immunological dysregulation that underlies periodontitis. These results underscore the importance of dietary composition, extending beyond caloric intake, in preserving oral health and minimizing chronic inflammatory states.

Dr. Giuseppe Mainas, lead postdoctoral researcher, emphasized the translational impact of these observations, stating that a balanced Mediterranean dietary pattern could serve as a non-pharmacological adjunct to conventional periodontal therapy. He elucidated that their data not only establish a link between dietary habits and gum disease severity but also encourage a holistic consideration of systemic inflammation in periodontal treatment planning.

Professor Luigi Nibali, senior author and Professor of Periodontology, reinforced the significance of nutrient density and plant-rich diets in promoting periodontal wellness. He acknowledged the emergent evidence positioning diet as a modifiable risk factor, advocating for personalized nutritional strategies that could complement traditional clinical interventions aimed at gum disease management.

Periodontal disease, a chronic inflammatory condition affecting the supporting structures of teeth, is primarily induced by microbial plaque accumulation but is heavily influenced by host immune response. This complex pathophysiology involves a dysregulated inflammatory cascade that, if unchecked, leads to tissue destruction and tooth loss. The role of systemic factors such as diet in modulating this immune response has garnered increasing scientific interest.

By systematically analyzing inflammatory biomarkers in conjunction with dietary patterns, the King’s College team bridges a critical knowledge gap. The data suggest that consumption of anti-inflammatory nutrients inherent in the Mediterranean diet can downregulate systemic inflammatory mediators, thereby potentially attenuating local periodontal inflammation and mitigating disease progression.

This research aligns with a growing body of literature highlighting the interconnectedness of systemic health and oral conditions. Chronic inflammation is a recognized contributor not only to periodontal pathology but also to an array of systemic diseases—underscoring the necessity for integrated approaches that incorporate lifestyle modifications alongside clinical treatment.

While the findings illuminate promising directions, the authors acknowledge the need for further longitudinal and interventional studies to establish causality and to optimize personalized nutritional recommendations. They advocate for the incorporation of dietary counseling into dental practice, envisioning a future where personalized dietetics become standard in periodontal care frameworks.

In conclusion, the King’s College London study provides robust evidence positioning the Mediterranean diet as a potential therapeutic ally in the battle against periodontal disease, emphasizing an integrative approach that harnesses the power of nutrition to promote oral and systemic health. As scientific inquiry into diet-inflammation interplay advances, these insights may revolutionize preventive and therapeutic strategies in dentistry and beyond.

Subject of Research: The relationship between Mediterranean-style diet adherence, periodontal disease severity, and systemic inflammation.

Article Title: (Not specified in the source content)

News Publication Date: (Not specified in the source content)

Web References: (Not specified in the source content)

References: Research published in the Journal of Periodontology by King’s College London researchers.

Image Credits: (Not specified in the source content)

Keywords: Diseases and disorders, Health and medicine, Periodontal disease, Mediterranean diet, Inflammation, Interleukin-6, C-reactive protein, Oral health, Nutritional science, Immune modulation, Chronic disease prevention

The Mediterranean diet, long celebrated for its cardiovascular and metabolic benefits, focuses on high consumption of fruits, vegetables, whole grains, nuts, and olive oil, coupled with moderate intake of lean proteins such as fish and poultry, and minimal red meat. While previous studies have linked this dietary pattern to improved insulin sensitivity and attenuation of systemic inflammation, this new trial sought to ascertain whether augmenting the diet with other lifestyle interventions would amplify its protective effect against type 2 diabetes onset. The innovative approach aimed to dissect the interplay between diet, calorie management, physical activity, and sustained behavioral support.

Involving 4,746 overweight and obese adults aged 55 to 75 with metabolic syndrome yet free from type 2 diabetes at baseline, the six-year study enrolled participants into two distinct groups. The intervention group adhered to a Mediterranean diet but also implemented a daily caloric reduction averaging 600 calories. This group engaged in structured moderate exercise that included brisk walking as well as strength and balance training, supported continuously by healthcare professionals specializing in weight management. In contrast, the control group followed an unrestricted Mediterranean diet without caloric limitation, personalized exercise guidance, or regular professional consultation.

Throughout the extensive follow-up period, researchers meticulously tracked the incidence of new type 2 diabetes cases alongside weight and waist circumference changes. The intervention cohort exhibited significantly enhanced outcomes, reflecting a 31% lower risk of developing diabetes compared to the control group. Beyond risk reduction, members of the intervention group experienced an average weight loss of 3.3 kilograms and a waist circumference decrease of 3.6 centimeters, underscoring the metabolic and adiposity-related benefits of integrating calorie control and exercise with the diet.

The biological underpinnings explaining these benefits are multifactorial. The Mediterranean diet’s nutrient-dense composition supports favorable lipid profiles, reduces oxidative stress, and modulates inflammatory pathways critical in insulin resistance. Caloric restriction may enhance mitochondrial efficiency and promote energy balance, while regular moderate physical activity improves glucose uptake and insulin signaling at the muscular level. Professional support facilitates behavioral adherence and psychological motivation, crucial components sustaining long-term health behavior change and metabolic improvements.

Co-author Frank Hu, Professor and Chair of the Department of Nutrition at Harvard Chan School, contextualized the study within the ongoing diabetes health crisis. He emphasized that these interventions, grounded in the highest caliber of randomized clinical evidence, could be scaled globally to curb the rising tide of diabetes. “Modest but sustained lifestyle adaptations are capable of preventing millions of cases,” Hu stated, advocating for widespread public health strategies that integrate diet, exercise, caloric moderation, and professional guidance.

This trial also sheds light on the challenge of maintaining lifestyle interventions over several years. While the Mediterranean diet has widespread acceptance, the adherence to caloric restriction and exercise regimens often wanes without consistent external support. By embedding professional counseling and personalized weight loss management into their protocol, the researchers addressed attrition barriers and maintained higher compliance, rendering the intervention practical and impactful in real-world settings.

The public health implications are profound. Given the increasing prevalence of obesity and metabolic syndrome—major risk factors for type 2 diabetes—this data signals a pivotal shift toward comprehensive, multifaceted prevention programs. Policymakers and healthcare providers may leverage these insights to design effective community-based interventions that combine dietary guidance with tangible behavioral and clinical support systems.

Importantly, the trial design reinforces the concept that nutritional quality alone, while critical, may not suffice in diabetes prevention. The additive effects of energy restriction, increased physical activity, and health professional intervention collectively generate a metabolic milieu less conducive to insulin resistance and beta-cell dysfunction. This integrated approach aligns with contemporary models of chronic disease prevention that recognize lifestyle as a complex web of interdependent factors rather than isolated elements.

The study’s rigorous methodology—a randomized controlled trial with a substantial sample size and lengthy follow-up—adds weight to the findings and enhances their generalizability across similar populations. Participants’ metabolic syndrome status and older age bracket further emphasize the intervention’s relevance for high-risk groups, who stand to benefit most from preemptive measures.

Funded by leading health institutions including the European Research Council and National Institutes of Health, the PREDIMED-Plus trial exemplifies international collaboration advancing science that bridges epidemiology, clinical nutrition, and behavioral health. Such alliances are essential in framing scalable solutions to address the complex biology and sociocultural drivers underpinning diabetes incidence globally.

In summary, this pivotal research confirms that a synergistic approach employing a calorie-reduced Mediterranean diet, structured physical activity, and ongoing professional weight loss support markedly diminishes the risk of developing type 2 diabetes in high-risk adults. The integration of these elements produces tangible metabolic benefits, reduced adiposity, and, ultimately, a lowered population burden of a chronic disease with devastating individual and societal costs. As the diabetes epidemic escalates unchecked, such evidence-based, multifactorial prevention strategies represent a beacon of hope for a healthier global future.

Subject of Research: People

Article Title: Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes

News Publication Date: August 25, 2025

Web References:
https://www.hsph.harvard.edu/news/
https://www.hsph.harvard.edu/studio/

References:
Miguel Ruiz-Canela, Dolores Corella, Miguel Ángel Martínez-González, et al. “Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes.” Annals of Internal Medicine, August 25, 2025. DOI: 10.7326/ANNALS-25-00388

Keywords: Diets, Dietetics, Caloric restriction, Nutrition counseling, Physical exercise, Nutrition, Diabetes, Type 2 diabetes